Statistics for Pacira BioSciences (id:7569 PCRX)

Valuation metrics

Market cap

766.48M

Enterprise value

957.09M

Trailing P/E (ttm)

13.14

Forward P/E

5.48

PEG ratio

5.48

Price/Sales (ttm)

1.10

Price/Book (mrq)

1.02

Enterprise Value/Revenue

1.38

Enterprise Value/EBITDA

5.38

Overview

Shares outstanding

46.17M

Float

45.67M

Shares short

5.46M

% Held by insiders

0.02%

% Held by institutions

1.15%

Average volume (10 days)

626.05K

Average volume (90 days)

Price summary

52-Week low

11.16

52-Week high

35.95

52-Week change

-58.02%

Beta

0.82

50-Day moving average

15.81

200-Day moving average

23.05

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-13.06%

Operating margin

13.02%

Operational effectiveness

Return on assets

4.17%

Return on equity

-11.48%

Income statement

Revenue (ttm)

15.01

Revenue per share (ttm)

15.01

Quarterly revenue growth (yoy)

Gross profit (ttm)

490.31M

EBITDA

192.82M

Net income to common (ttm)

-90,731,000.00

Diluted EPS (ttm)

-1.98

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

453.81M

Total cash per share (mrq)

9.83

Total debt (mrq)

644.42M

Total Debt/Equity (mrq)

85.97

Current ratio (mrq)

225.20%

Book value per share (mrq)

16.24

Cash flow

Cash flow statement

203.84M

Levered free cash flow (LFCF)

169.56M